This looks like a breakout waiting to happen

Hey Folks, Jeff Bishop here,

Stocks pushed higher today as traders are increasingly pricing in the possibility of a ceasefire in the Iran conflict.

The S&P climbed about 0.7%, Nasdaq over 1%…

And oil actually pulled back as tensions (somewhat) ease.

It’s no secret that volatility has been off the charts since the war started. That’s why I’ve been shocked to watch a small-cap biotech I’ve been tracking surge over 100% in just the past month.

Investors are excited about a fresh influx of institutional money and a stacked lineup of upcoming catalysts.

The company just closed a $30 million private placement led by healthcare-focused funds — the kind of investors who don’t throw money around casually.

Its lead candidate has received no fewer than five FDA designations.

And it has pivotal clinical data expected later this year, which could completely reprice the stock if things go right.

The setup is a stock already showing strong momentum, institutional capital pouring in, and a clear timeline of catalysts ahead.

I’m watching it closely for a “second leg” move.

I’ve broken everything down right here:

👉 View Today’s Tactical Trade Idea Here 👈

Be sure to check this one out before the bell. It’s already been on the move and you’ll want to watch carefully for another leg up.

To Your Success,